Aspen Pharmacare to Sell Asia-Pacific Assets to BGH Capital for $1.59 Billion

We are witnessing a major strategic transformation as Aspen Pharmacare moves to sell its Asia-Pacific assets to private equity firm BGH Capital for $1.59 billion. This transaction stands as one of the most important developments in the global pharmaceutical sector this year. It reflects a deliberate effort to reshape operations, unlock value, and strengthen financial resilience in a rapidly changing stock market environment.